Vertex Pharmaceuticals Incorporated
METHODS OF TREATMENT FOR ALPHA-1 ANTITRYPSIN DEFICIENCY

Abstract:

This application describes methods of treating alpha-1 antitrypsin deficiency (AATD) comprising administering Compound I, a deuterated derivative thereof, and/or a pharmaceutically acceptable salt thereof. ##STR00001## The application also describes pharmaceutical compositions comprising Compound I, a deuterated derivative thereof, and/or a pharmaceutically acceptable salt thereof.